WADDEN, T.; TRONIERI, J. S.; SUGIMOTO, D.; LUND, M. T.; AUERBACH, P.; JENSEN, C.; RUBINO, D. .; PASAMBA, C. Q. LIRAGLUTIDE 3.0 mg AS AN ADJUNCT TO INTENSIVE BEHAVIOR THERAPY IN INDIVIDUALS WITH OBESITY: SCALE IBT 56-WEEK RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED TRIAL. Journal of the ASEAN Federation of Endocrine Societies, [S. l.], v. 34, n. 2, p. 9–10, 2022. Disponível em: https://asean-endocrinejournal.org/index.php/JAFES/article/view/1853. Acesso em: 5 may. 2024.